Connect with us

Coronavirus Outbreak

Researchers At Noida University Discover Molecule With Potential To Treat COVID-19

The new discovery made by researchers at Shiv Nadar University, Noida would prevent COVID-19 from affecting human lungs along with addressing lung injuries already inflicted by the virus, according to the lead researcher

Researchers At Noida University Discover Molecule With Potential To Treat COVID-19
Highlights
  • Shiv Nadar University researchers have found molecule to fight COVID-19
  • This discovery will be useful in developing COVID-19 drugs: Vice Chancellor
  • Newly discovered compound will be ready for human trials by the year end

New Delhi: Researchers at Shiv Nadar University have discovered a set of chemical molecules that have the potential to cure acute respiratory distress syndrome (ARDS) caused by coronavirus infection, the Noida-based private university claimed on Tuesday. The team of researchers led by Professor Subhabrata Sen from the Department of Chemistry expects to complete the pre-clinical studies by the end of this year and after which the compound will be potentially ready for human trials, the university said in a statement.

Also Read: Coronavirus Outbreak Explained: What Is Pool Testing And Can It Expedite COVID-19 Detection In The Country?

The new chemical entities (NCEs) hold potential to cure acute respiratory distress syndrome (ARDS) induced by COVID-19 or other severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS), according to the statement.

The researchers have filed a provisional patent in India to protect the new chemical entities and the novel molecule in discovery is being moved to the next stage of checking where its efficacy will be tested on animals.

According to the researchers, the therapy would not only prevent COVID-19 from affecting a person’s lungs but will also address lung injuries already inflicted by the virus, in cases, the ventilators are either not proving effective or are not available altogether that would bring in relief to COVID-19 patients suffering from ARDS. Professor Sen said,

We hope our therapeutic approach will unravel solutions against maladies associated with acute respiratory distress syndrome. Our aim is to conclude the preclinical studies by the end of this year, post which the new compound will potentially be ready for the next stage of development along with human trials.

Also Read: Combating COVID-19: Patient Treated With Plasma Therapy In Delhi Recovers, Discharged

The two-fold strategy devised by the research team involved the application of the NCEs to inhibit attachment, entry and infection of the new coronavirus through a known target on the virus and co-administration of a known drug (that modulates a set of hormonal receptors in human) and these NCEs to attenuate ARDS caused by the novel coronavirus, Sen said. Shiv Nadar University vice-chancellor Rupamanjari Ghosh said,

This particular research holds out the promise for a drug that can combat COVID-19, SARS and MERS – this is highly commendable.

Also Read: COVID-19 Vaccine Must Be Considered Public Good With Universal Availability: UN Chief

World

23,96,06,768Cases
20,13,42,617Active
3,33,82,100Recovered
48,82,051Deaths
Coronavirus has spread to 195 countries. The total confirmed cases worldwide are 23,96,06,768 and 48,82,051 have died; 20,13,42,617 are active cases and 3,33,82,100 have recovered as on October 15, 2021 at 4:15 am.

India

3,40,37,592 16,862Cases
2,03,6782,908Active
3,33,82,100 19,391Recovered
4,51,814 379Deaths
In India, there are 3,40,37,592 confirmed cases including 4,51,814 deaths. The number of active cases is 2,03,678 and 3,33,82,100 have recovered as on October 15, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

65,86,280 2,384

33,157 6

64,13,418 2,343

1,39,705 35

Kerala

48,29,944 9,246

96,421 1,802

47,06,856 10,952

26,667 96

Karnataka

29,82,399 310

9,607 43

29,34,870 347

37,922 6

Tamil Nadu

26,83,396 1,259

15,451 199

26,32,092 1,438

35,853 20

Andhra Pradesh

20,59,122 540

6,588 27

20,38,248 557

14,286 10

Uttar Pradesh

17,10,008 12

135 4

16,86,976 16

22,897

West Bengal

15,79,012 530

7,576 81

15,52,491 601

18,945 10

Delhi

14,39,311 28

337 1

14,13,885 29

25,089

Odisha

10,33,809 521

4,890 38

10,20,645 477

8,274 6

Chhattisgarh

10,05,614 16

203 4

9,91,841 20

13,570

Rajasthan

9,54,382 8

42 6

9,45,386 2

8,954

Gujarat

8,26,244 34

215 20

8,15,943 14

10,086

Madhya Pradesh

7,92,669 12

111 1

7,82,035 11

10,523

Haryana

7,71,035 16

105 158

7,60,881

10,049 174

Bihar

7,26,016 8

42 6

7,16,313 2

9,661

Telangana

6,68,618 168

4,171 40

6,60,512 207

3,935 1

Assam

6,05,847 207

3,646 157

5,96,263 362

5,938 2

Punjab

6,01,971 33

234 11

5,85,199 16

16,538 6

Jharkhand

3,48,406 11

130 4

3,43,141 7

5,135

Uttarakhand

3,43,729 28

175 22

3,36,157 6

7,397

Jammu And Kashmir

3,30,834 93

935 11

3,25,473 104

4,426

Himachal Pradesh

2,21,113 182

1,387 5

2,16,011 173

3,715 4

Goa

1,77,356 68

679 27

1,73,342 39

3,335 2

Puducherry

1,27,259 49

647 4

1,24,763 53

1,849

Manipur

1,22,432 69

1,444 15

1,19,099 84

1,889

Mizoram

1,10,719 901

13,601 435

96,744 1,332

374 4

Tripura

84,295 4

110 8

83,369 12

816

Meghalaya

82,734 87

892 31

80,411 115

1,431 3

Chandigarh

65,295 10

32 5

64,443 15

820

Arunachal Pradesh

54,958 4

202 22

54,476 26

280

Sikkim

31,722 6

224 1

31,108 7

390

Nagaland

31,516 9

230 8

30,613 17

673

Ladakh

20,867 6

44 2

20,615 4

208

Dadra And Nagar Haveli

10,675

3 1

10,668 1

4

Lakshadweep

10,365

2 0

10,312

51

Andaman And Nicobar Islands

7,640 3

10 1

7,501 2

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Highlights From The 12-Hour Telethon

Leaving No One Behind

Mental Health

Environment

Join Us